Oct 31 (Reuters) - Aerovate Therapeutics Inc :
* AEROVATE THERAPEUTICS - EXCHANGE RATIO ASSUMES VALUATION FOR AEROVATE OF $8.0 MILLION AND VALUATION FOR JADE OF $175.0 MILLION
* AEROVATE THERAPEUTICS - UPON TERMINATION OF DEAL UNDER SPECIFIED CIRCUMSTANCES, CO MAY BE REQUIRED TO PAY JADE TERMINATION FEE OF $2.3 MILLION
* AEROVATE THERAPEUTICS - UPON TERMINATION OF DEAL UNDER CERTAIN CIRCUMSTANCES, JADE MAY BE REQUIRED TO PAY CO TERMINATION FEE OF $5.3 MILLION
Source text: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments